Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 1996

View Archived Issues

Takeda claims new treatments for pancreatitis

Regeneron claims novel use for neurotrophic factor

Schering-Plough claims novel use for Flt3 ligand

New antithrombotic agents described by Pfizer

New antiplatelet drugs from Takeda

LHRH antagonists under study at Takeda

Boehringer Ingelheim's modified anti-ICAM-1 antibodies for inflammatory disorders

Agents for urinary incontinence reported by Dainippon

NIH HIV immunoassay licensed to IGEN

QLT signs European licensing agreement for photosensitizer

Biomerica and Bentley sign marketing and distribution agreement

Biomatrix-Boehringer Ingelheim Synvisc agreement

Third approval for Parke-Davis HMG-CoA reductase inhibitor

Anti-CD2 MAb enters phase II for GVHD

ALRT-1550 to enter clinical trials

Additional filings and positive clinical results for Zadaxin

First Rx for oral ulcers cleared by FDA

Sanofi Winthrop returns diagnostics imaging rights to Nycomed

ImClone and Immunex crosslicense flt3/flk-2 technology

LIDAK develops drug discovery approach for asthma

Northwest Neurologic and Wyeth-Ayerst neurodegenerative disorder collaboration

Forest cleared to market new treatment for cystitis

IND filed for Cytel HIV therapeutic vaccine

Algos and Interneuron codevelop novel antimigraine combination

Androsorb cleared for clinical trials

Immunomedics files for approval of imaging agent for infectious disease

NanoSystems to develop novel formulation of HIV protease inhibitor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...